Cancers in Vietnam-Burden and Control Efforts: A Narrative Scoping Review.


Journal

Cancer control : journal of the Moffitt Cancer Center
ISSN: 1526-2359
Titre abrégé: Cancer Control
Pays: United States
ID NLM: 9438457

Informations de publication

Date de publication:
Historique:
entrez: 20 7 2019
pubmed: 20 7 2019
medline: 7 1 2020
Statut: ppublish

Résumé

Although the burden of cancer is rapidly growing in Vietnam, there was no up-to-date review that describes cancer burden and control in Vietnam throughout the literature. By identifying various risk factors, means of prevention, and methods for early detection, this review seeks to systematically summarize the evidence for the future planning and management of cancer occurrence in Vietnam. Additionally, this report aims to identify improvements which are necessary for the treatment and palliative care of patients with cancer in Vietnam. We employed a hybrid approach including both a scoping review and narrative synthesis for this study. Information was identified, extracted, and charted from various sources, which include international and domestically published studies, in addition to gray literature. Our results illustrate that the burden of cancer in Vietnam has tripled in the past 30 years, and this situation could be partly explained by the growing prevalence of both old and new risk factors. Besides hepatitis B virus, various other important risk factors such as human papilloma virus, tobacco usage, physical inactivity, and improper diets are still not under control in Vietnam. There is presently a lack of national cancer screening programs, and the capacity of cancer care services could not maintain pace with the demands of a rapidly increasing Vietnamese population. Overall, policy frameworks for cancer control in Vietnam are in place, but there is still a lack of proper financing and governing models necessary to support a sustainable program. In conclusion, Cancer and its associated consequences are both persistent and emerging problems in Vietnam, and the results of cancer control programs are limited. A comprehensive and evidence-based approach toward the prevention and treatment of cancer should be the future direction for Vietnam.

Identifiants

pubmed: 31319695
doi: 10.1177/1073274819863802
pmc: PMC6643189
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1073274819863802

Subventions

Organisme : NCI NIH HHS
ID : P20 CA210300
Pays : United States

Références

Int J Public Health. 2017 Feb;62(Suppl 1):121-129
pubmed: 28229183
Glob Health Action. 2013 Feb 04;6:18872
pubmed: 23394855
Cancer Causes Control. 2009 Jul;20(5):721-30
pubmed: 19123056
J Pediatr Hematol Oncol. 2014 Oct;36(7):534-40
pubmed: 24322500
Vaccine. 2008 Jul 29;26(32):4015-24
pubmed: 18602731
Lancet. 2014 Feb 22;383(9918):678-9
pubmed: 24055453
Jpn J Clin Oncol. 2002 Mar;32 Suppl:S92-7
pubmed: 11959882
Eur J Cancer. 2017 Mar;74:26-37
pubmed: 28335885
Mol Vis. 2018 Mar 17;24:231-238
pubmed: 29568217
Liver Int. 2008 Apr;28(4):525-31
pubmed: 18266635
Glob Health Action. 2009 Dec 20;2:
pubmed: 20057939
J Surg Oncol. 2017 Apr;115(5):591-602
pubmed: 28345140
Int J Cancer. 2011 Aug 1;129(3):517-27
pubmed: 21384341
Int J Health Policy Manag. 2014 Nov 08;3(6):297-9
pubmed: 25396204
Asian Pac J Cancer Prev. 2014;15(22):9747-51
pubmed: 25520098
Asia Pac J Public Health. 2014 Sep;26(5):527-35
pubmed: 24285779
Lancet. 2010 Oct 2;376(9747):1186-93
pubmed: 20709386
J Gastroenterol Hepatol. 2007 Dec;22(12):2093-100
pubmed: 17645465
Glob Health Action. 2013 Jan 17;6:1-9
pubmed: 23336619
Asian Pac J Cancer Prev. 2012;13(1):37-40
pubmed: 22502703
Eur J Oncol Nurs. 2016 Apr;21:242-7
pubmed: 26552650
Vaccine. 2008 Aug 19;26 Suppl 12:M71-9
pubmed: 18945416
Vaccine. 2008 Aug 19;26 Suppl 12:M17-29
pubmed: 18945411
J Prev Med Public Health. 2014 Jul;47(4):183-200
pubmed: 25139165
Arch Environ Health. 1996 Sep-Oct;51(5):368-74
pubmed: 8896386
Int J Cancer. 2017 Aug 15;141(4):664-670
pubmed: 28369882
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Asian J Psychiatr. 2016 Oct;23:95-98
pubmed: 27969088
Am J Clin Pathol. 2017 Nov 20;148(6):529-537
pubmed: 29140404
Arch Environ Contam Toxicol. 1997 Nov;33(4):453-6
pubmed: 9419265
J Oral Pathol Med. 2008 Oct;37(9):511-4
pubmed: 18624933
Cancer Sci. 2010 Mar;101(3):579-85
pubmed: 20085587
Asia Pac J Public Health. 2012 Mar;24(2):385-90
pubmed: 21362673
Prev Med. 2013 Sep;57(3):232-7
pubmed: 23732238
Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):83-6
pubmed: 19469630
Asia Pac J Clin Nutr. 2018;27(1):19-28
pubmed: 29222878
Int J Cancer. 2004 Jul 10;110(5):775-7
pubmed: 15146569
Int J Cancer. 1993 Sep 9;55(2):196-201
pubmed: 7690345
Asian Pac J Cancer Prev. 2012;13(2):411-20
pubmed: 22524799
J Infect Dis. 2009 May 15;199(10):1449-56
pubmed: 19351262
Int J Cancer. 2003 Mar 20;104(2):213-20
pubmed: 12569577
Oncol Res. 2010;18(7):349-55
pubmed: 20377137
Asian Pac J Cancer Prev. 2011;12(2):561-6
pubmed: 21545230
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Urol Oncol. 2010 Nov-Dec;28(6):673-6
pubmed: 21062650
Diagn Cytopathol. 2012 Apr;40(4):355-66
pubmed: 21394935
Worldviews Evid Based Nurs. 2016 Apr;13(2):118-23
pubmed: 26821833
ESMO Open. 2018 Feb 2;3(2):e000285
pubmed: 29464109
Cancer Res Treat. 2017 Oct;49(4):990-1000
pubmed: 28231427
Oncologist. 2013;18(12):1278-84
pubmed: 24217554
Lancet Glob Health. 2016 Jul;4(7):e453-63
pubmed: 27340003
J Pain Symptom Manage. 2006 May;31(5):431-9
pubmed: 16716873
Microrna. 2018;7(2):92-99
pubmed: 29701140
Asian Pac J Cancer Prev. 2012;13(5):1767-70
pubmed: 22901119
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):41-7
pubmed: 15668474
BMC Health Serv Res. 2017 May 15;17(1):353
pubmed: 28506297
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Biomed Res Int. 2017;2017:9350147
pubmed: 28904976
Int J Gynecol Cancer. 2013 Jan;23(1):148-56
pubmed: 23221730
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Nutrients. 2018 Jan 11;10(1):
pubmed: 29324670
J Pain Symptom Manage. 2007 May;33(5):578-83
pubmed: 17482051
Asian Pac J Cancer Prev. 2010;11(3):739-45
pubmed: 21039046
BMC Cancer. 2013 Feb 04;13:53
pubmed: 23374877
Anticancer Res. 2017 Mar;37(3):1243-1247
pubmed: 28314288

Auteurs

Tung Pham (T)

1 Department of Physiology, Hanoi Medical University, Hanoi, Vietnam.
2 Center for Population Health Science, Hanoi University of Public Health, Hanoi, Vietnam.

Linh Bui (L)

2 Center for Population Health Science, Hanoi University of Public Health, Hanoi, Vietnam.

Giang Kim (G)

3 Department of Health Education, Hanoi Medical University, Hanoi, Vietnam.

Dong Hoang (D)

4 Vietnam National Cancer Institute, National Cancer Hospital, Hanoi, Vietnam.

Thuan Tran (T)

4 Vietnam National Cancer Institute, National Cancer Hospital, Hanoi, Vietnam.

Minh Hoang (M)

5 Department of Health Economics, Hanoi University of Public Health, Hanoi, Vietnam.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH